Embody Completes $10.4M Series C Financing
Summary
NORFOLK, VA, Embody, a medical device company focused on soft tissue healing, announced today that it closed a $10.4 million Series C funding round. The round was led by Genesis Innovation Groups cultivate(MD) Capital Funds LP. The financing will enable Embody to expand its world-class operations, post-market clinical studies of the recently launched Tapestry RC System for rotator cuff and prepare for the commercial launch of ActivBraid high-strength collagen-based suture technology in 2023. Embody, the soft tissue healing company, is pioneering the next generation regenerative platform with novel collagen-based bio-fabrication techniques and products for the fast-growing sports medicine market. Embodys products focus on the most pressing patient needs: the repair of serious tendon and ligament injuries and are developed in close collaboration with some of the most advanced clinical thought leaders.